ArticleAbdominal radiology (New York)2026
A novel CT-based normalization strategy using lesion-to-spleen density ratios for renal mass characterization.
Article in Abdominal radiology (New York), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeAccurate preoperative characterization of renal masses remains a major clinical challenge, as a substantial proportion of surgically resected lesions ultimately prove to be benign. Absolute Hounsfield unit (HU) measurements on contrast-enhanced computed tomography (CT) are widely used but are vulnerable to technical and patient-related variability. This study aimed to introduce and evaluate a novel CT-based normalization strategy using lesion-to-organ HU ratios to improve differentiation between benign and malignant renal masses and to explore its performance across renal cell carcinoma (RCC) subtypes.
methodsThis retrospective single-center study included 248 patients with histopathologically confirmed renal tumors who underwent multiphasic CT. Attenuation values were measured from the lesion, contralateral renal cortex, and spleen on both non-contrast and contrast-enhanced images. Lesion-to-kidney (LK) and lesion-to-spleen (LS) HU ratios were calculated. Diagnostic performance was evaluated using receiver operating characteristic (ROC) analysis, and predictors of malignancy were assessed with univariate and multivariate logistic regression. Subgroup analysis was performed across RCC subtypes.
resultsBoth contrast-enhanced lesion-to-kidney (CE-LK) and lesion-to-spleen (CE-LS) HU ratios differed significantly between benign and malignant lesions (p < 0.01). The CE-LK HU ratio demonstrated excellent diagnostic performance (AUC = 0.914), achieving 83.8% sensitivity and 100% specificity at a cut-off of ≤ 0.76. The CE-LS HU ratio showed similarly high accuracy (AUC = 0.883), with 87.4% sensitivity and 87.5% specificity at a cut-off of ≤ 0.89. In multivariate analysis adjusting for lesion size and absolute enhancement, only the CE-LS HU ratio remained an independent predictor of malignancy (OR = 36.9, p = 0.004). Subtype analysis revealed that papillary RCC exhibited significantly lower CE-LS HU ratios compared with clear cell RCC (p = 0.020), while no significant differences were observed between chromophobe RCC and other subtypes.
conclusionLesion-to-spleen HU normalization is a simple, reproducible, and broadly applicable CT-based approach that enhances renal mass characterization and may aid in reducing unnecessary surgical interventions.
Indexed as
Identifiers
42029686What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.